• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

益生菌:它们在对抗肥胖方面有多有效?

Probiotics: How Effective Are They in the Fight against Obesity?

机构信息

Department of Basic Medical Sciences, College of Osteopathic Medicine, Western University of Health Sciences, Pomona, CA 91766, USA.

Department of Health and Human Development, University of Suceava, Suceava 720229, Romania.

出版信息

Nutrients. 2019 Jan 24;11(2):258. doi: 10.3390/nu11020258.

DOI:10.3390/nu11020258
PMID:30678355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6412733/
Abstract

Obesity has been associated with structural and functional changes in the gut microbiota. The abundance in, and diversity of, certain bacteria may favor energy harvest and metabolic pathways leading to obesity. Therefore, gut microbiota has become a potential target that can be manipulated to obtain optimal health. Probiotics have been shown to influence the composition of the gut microbiota, improve gut integrity, and restore the microbial shifts characteristic of obesity. Based on physical and biochemical parameters, metabolic and inflammatory markers, and alterations in gut microbe diversity, animal studies revealed beneficial results in obese models whereas the results in humans are sparse and inconsistent. Thus, the purpose of this review is to present evidence from animal studies and human clinical trials demonstrating the effects of various probiotic strains and their potential efficacy in improving obesity and associated metabolic dysfunctions. Furthermore, the review discusses current gaps in our understanding of how probiotics modulate gut microflora to protect against obesity. Finally, we propose future studies and methodological approaches that may shed light on the challenges facing the scientific community in deciphering the host⁻bacteria interaction in obesity.

摘要

肥胖与肠道微生物群的结构和功能变化有关。某些细菌的丰度和多样性可能有利于能量的获取和导致肥胖的代谢途径。因此,肠道微生物群已成为一个潜在的靶点,可以通过操纵它来获得最佳的健康状态。益生菌已被证明可以影响肠道微生物群的组成,改善肠道完整性,并恢复肥胖特征的微生物转移。基于物理和生化参数、代谢和炎症标志物以及肠道微生物多样性的改变,动物研究显示出肥胖模型的有益结果,而人体研究结果则很少且不一致。因此,本综述的目的是提供来自动物研究和人类临床试验的证据,证明各种益生菌菌株的作用及其在改善肥胖和相关代谢功能障碍方面的潜在功效。此外,本综述还讨论了我们对益生菌如何调节肠道微生物群以预防肥胖的理解存在的差距。最后,我们提出了未来的研究和方法途径,这可能有助于阐明科学界在解析肥胖宿主-细菌相互作用方面所面临的挑战。

相似文献

1
Probiotics: How Effective Are They in the Fight against Obesity?益生菌:它们在对抗肥胖方面有多有效?
Nutrients. 2019 Jan 24;11(2):258. doi: 10.3390/nu11020258.
2
Gut microbiota and probiotics: Focus on diabetes mellitus.肠道微生物群和益生菌:关注糖尿病。
Crit Rev Food Sci Nutr. 2017 Jul 24;57(11):2296-2309. doi: 10.1080/10408398.2014.934438.
3
Gut microbiota is associated with adiposity markers and probiotics may impact specific genera.肠道微生物群与肥胖标志物有关,益生菌可能影响特定属。
Eur J Nutr. 2020 Jun;59(4):1751-1762. doi: 10.1007/s00394-019-02034-0. Epub 2019 Jun 27.
4
Continuously Ingesting Fructooligosaccharide Can't Maintain Rats' Gut Bifidobacterium at a High Level.持续摄入低聚果糖无法使大鼠肠道双歧杆菌维持在高水平。
J Food Sci. 2015 Nov;80(11):M2530-4. doi: 10.1111/1750-3841.13086. Epub 2015 Oct 7.
5
Probiotic Strains and Intervention Total Doses for Modulating Obesity-Related Microbiota Dysbiosis: A Systematic Review and Meta-analysis.益生菌菌株和干预总剂量调节肥胖相关肠道菌群失调:系统评价和荟萃分析。
Nutrients. 2020 Jun 29;12(7):1921. doi: 10.3390/nu12071921.
6
Probiotic Species in the Modulation of Gut Microbiota: An Overview.益生菌物种对肠道微生物群的调节:概述。
Biomed Res Int. 2018 May 8;2018:9478630. doi: 10.1155/2018/9478630. eCollection 2018.
7
Probiotic strains and mechanistic insights for the treatment of type 2 diabetes.用于治疗 2 型糖尿病的益生菌菌株和作用机制研究进展。
Endocrine. 2017 Nov;58(2):207-227. doi: 10.1007/s12020-017-1433-z. Epub 2017 Oct 19.
8
Immunology and probiotic impact of the newborn and young children intestinal microflora.新生儿和幼儿肠道微生物菌群的免疫学和益生菌影响。
Anaerobe. 2011 Dec;17(6):369-74. doi: 10.1016/j.anaerobe.2011.03.010. Epub 2011 Apr 16.
9
Restoration of cefixime-induced gut microbiota changes by Lactobacillus cocktails and fructooligosaccharides in a mouse model.在小鼠模型中,用乳酸菌组合和低聚果糖恢复头孢克肟引起的肠道微生物群变化。
Microbiol Res. 2017 Jul;200:14-24. doi: 10.1016/j.micres.2017.04.001. Epub 2017 Apr 5.
10
Is It Time to Use Probiotics to Prevent or Treat Obesity?是否到了使用益生菌来预防或治疗肥胖的时候了?
Nutrients. 2018 Nov 1;10(11):1613. doi: 10.3390/nu10111613.

引用本文的文献

1
Multi-strain probiotics attenuate carbohydrate-lipid metabolic dysregulation in type 2 diabetic rats via gut-liver axis modulation.多菌株益生菌通过调节肠-肝轴减轻2型糖尿病大鼠的碳水化合物-脂质代谢失调。
mSystems. 2025 Jul 22;10(7):e0036925. doi: 10.1128/msystems.00369-25. Epub 2025 Jun 10.
2
Supplementation of mixed alleviates metabolic impairment, inflammation, and dysbiosis of the gut microbiota in an obese mouse model.混合补充剂可减轻肥胖小鼠模型中的代谢损伤、炎症及肠道微生物群失调。
Front Nutr. 2025 Mar 26;12:1554996. doi: 10.3389/fnut.2025.1554996. eCollection 2025.
3
Synergistic Effects of Probiotics and Lifestyle Interventions on Intestinal Microbiota Composition and Clinical Outcomes in Obese Adults.益生菌与生活方式干预对肥胖成年人肠道微生物群组成及临床结局的协同作用
Metabolites. 2025 Jan 23;15(2):70. doi: 10.3390/metabo15020070.
4
Mechanism of Action and Beneficial Effects of Probiotics in Amateur and Professional Athletes.益生菌对业余和职业运动员的作用机制及有益效果
Food Sci Nutr. 2024 Dec 12;13(1):e4658. doi: 10.1002/fsn3.4658. eCollection 2025 Jan.
5
Understanding the complex function of gut microbiota: its impact on the pathogenesis of obesity and beyond: a comprehensive review.理解肠道微生物群的复杂功能:其对肥胖及其他疾病发病机制的影响:综述
Diabetol Metab Syndr. 2024 Dec 23;16(1):308. doi: 10.1186/s13098-024-01561-z.
6
Effects of Bifidobacterium and rosuvastatin on metabolic-associated fatty liver disease via the gut-liver axis.双歧杆菌和瑞舒伐他汀通过肠-肝轴对代谢相关脂肪性肝病的影响。
Lipids Health Dis. 2024 Dec 18;23(1):401. doi: 10.1186/s12944-024-02391-8.
7
Probiotics, prebiotics, synbiotics and other microbiome-based innovative therapeutics to mitigate obesity and enhance longevity via the gut-brain axis.益生菌、益生元、合生元及其他基于微生物群的创新疗法,通过肠-脑轴减轻肥胖并延长寿命。
Microbiome Res Rep. 2024 May 17;3(3):29. doi: 10.20517/mrr.2024.05. eCollection 2024.
8
The role of gut microbiota augmentation in managing non-alcoholic fatty liver disease: an in-depth umbrella review of meta-analyses with grade assessment.肠道微生物群增强在非酒精性脂肪性肝病管理中的作用:一项带有分级评估的荟萃分析的深入系统性综述
Ann Med Surg (Lond). 2024 Jun 20;86(8):4714-4731. doi: 10.1097/MS9.0000000000002276. eCollection 2024 Aug.
9
Efficacy of Probiotic Strains Probio65 and Probio-093 in Management of Obesity: An In Vitro and In Vivo Analysis.益生菌菌株Probio65和Probio - 093在肥胖管理中的功效:一项体外和体内分析
Pharmaceuticals (Basel). 2024 May 24;17(6):676. doi: 10.3390/ph17060676.
10
High fat diet increases the severity of collagen-induced arthritis in mice by altering the gut microbial community.高脂饮食通过改变肠道微生物群落增加了胶原诱导性关节炎在小鼠中的严重程度。
Adv Rheumatol. 2024 May 30;64(1):44. doi: 10.1186/s42358-024-00382-y.

本文引用的文献

1
The Potential of Gut Commensals in Reinforcing Intestinal Barrier Function and Alleviating Inflammation.肠道共生菌在增强肠道屏障功能和缓解炎症方面的潜力。
Nutrients. 2018 Jul 29;10(8):988. doi: 10.3390/nu10080988.
2
Human gut microbiome: hopes, threats and promises.人类肠道微生物组:希望、威胁和承诺。
Gut. 2018 Sep;67(9):1716-1725. doi: 10.1136/gutjnl-2018-316723. Epub 2018 Jun 22.
3
Dose-Dependent Effects of Multispecies Probiotic Supplementation on the Lipopolysaccharide (LPS) Level and Cardiometabolic Profile in Obese Postmenopausal Women: A 12-Week Randomized Clinical Trial.多菌种益生菌补充剂对肥胖绝经后妇女内毒素(LPS)水平和心脏代谢特征的剂量依赖性影响:一项为期 12 周的随机临床试验。
Nutrients. 2018 Jun 15;10(6):773. doi: 10.3390/nu10060773.
4
Major microbiota dysbiosis in severe obesity: fate after bariatric surgery.严重肥胖症中的主要微生物失调:减肥手术后的命运。
Gut. 2019 Jan;68(1):70-82. doi: 10.1136/gutjnl-2018-316103. Epub 2018 Jun 13.
5
The development of probiotics therapy to obesity: a therapy that has gained considerable momentum.益生菌疗法治疗肥胖症的发展:一种备受关注的疗法。
Hormones (Athens). 2018 Jun;17(2):141-151. doi: 10.1007/s42000-018-0003-y. Epub 2018 Apr 16.
6
Probiotic Species in the Modulation of Gut Microbiota: An Overview.益生菌物种对肠道微生物群的调节:概述。
Biomed Res Int. 2018 May 8;2018:9478630. doi: 10.1155/2018/9478630. eCollection 2018.
7
Strain Ln4 Attenuates Diet-Induced Obesity, Insulin Resistance, and Changes in Hepatic mRNA Levels Associated with Glucose and Lipid Metabolism.菌株 Ln4 可减轻饮食诱导的肥胖、胰岛素抵抗以及与葡萄糖和脂质代谢相关的肝 mRNA 水平的变化。
Nutrients. 2018 May 19;10(5):643. doi: 10.3390/nu10050643.
8
Lactobacillus paracasei HII01, xylooligosaccharides, and synbiotics reduce gut disturbance in obese rats.副干酪乳杆菌 HII01、木低聚糖和合生菌可减少肥胖大鼠的肠道紊乱。
Nutrition. 2018 Oct;54:40-47. doi: 10.1016/j.nut.2018.03.005. Epub 2018 Mar 20.
9
The gut microbiota and its potential role in obesity.肠道微生物群及其在肥胖中的潜在作用。
Future Microbiol. 2018 Apr;13:589-603. doi: 10.2217/fmb-2017-0179. Epub 2018 Mar 13.
10
Probiotic supplementation increases obesity with no detectable effects on liver fat or gut microbiota in obese Hispanic adolescents: a 16-week, randomized, placebo-controlled trial.补充益生菌会增加肥胖风险,对肥胖西班牙裔青少年的肝脏脂肪或肠道微生物群没有可检测到的影响:一项为期16周的随机安慰剂对照试验。
Pediatr Obes. 2018 Nov;13(11):705-714. doi: 10.1111/ijpo.12273. Epub 2018 Feb 28.